Items per page
Sort by

Send to:

Choose Destination

Results: 10


Recombinant streptokinase vs phenylephrine-based suppositories in acute hemorrhoids, randomized, controlled trial (THERESA-3).

Hernández-Bernal F, Castellanos-Sierra G, Valenzuela-Silva CM, Catasús-Álvarez KM, Valle-Cabrera R, Aguilera-Barreto A, López-Saura PA; THERESA-3 Group of Investigators.

World J Gastroenterol. 2014 Feb 14;20(6):1594-601. doi: 10.3748/wjg.v20.i6.1594.


Specific active immunotherapy with a VEGF vaccine in patients with advanced solid tumors. results of the CENTAURO antigen dose escalation phase I clinical trial.

Gavilondo JV, Hernández-Bernal F, Ayala-Ávila M, de la Torre AV, de la Torre J, Morera-Díaz Y, Bequet-Romero M, Sánchez J, Valenzuela CM, Martín Y, Selman-Housein KH, Garabito A, Lazo OC; CENTAURO Group of Investigators.

Vaccine. 2014 Apr 17;32(19):2241-50. doi: 10.1016/j.vaccine.2013.11.102. Epub 2014 Feb 11.


Recombinant streptokinase suppositories in the treatment of acute haemorrhoidal disease. Multicentre randomized double-blind placebo-controlled trial (THERESA-2).

Hernández-Bernal F, Valenzuela-Silva CM, Quintero-Tabío L, Castellanos-Sierra G, Monterrey-Cao D, Aguilera-Barreto A, López-Saura P; THERESA-2 Group of Investigators.

Colorectal Dis. 2013 Nov;15(11):1423-8. doi: 10.1111/codi.12327.


Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults.

Hernández-Bernal F, Aguilar-Betancourt A, Aljovin V, Arias G, Valenzuela C, de Alejo KP, Hernández K, Oquendo O, Figueredo N, Figueroa N, Musacchio A, Véliz G, García E, Mollineda AD, Juvier AI, Trujillo J, Delahanty A, Ortega D, Cinza Z, González VL.

Hum Vaccin. 2011 Oct;7(10):1026-36. doi: 10.4161/hv.7.10.15989. Epub 2011 Oct 1.


Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction.

Betancourt BY, Marrero-Miragaya MA, Jiménez-López G, Valenzuela-Silva C, García-Iglesias E, Hernández-Bernal F, Debesa-García F, González-López T, Alvarez-Falcón L, López-Saura PA; Cuban National Network of Pharmacoepidemiology.

BMC Clin Pharmacol. 2005 Nov 2;5:5.


Bioequivalence of two recombinant granulocyte colony-stimulating factor formulations in healthy male volunteers.

Hernández-Bernal F, García-García I, González-Delgado CA, Valenzuela-Silva C, Soto-Hernández R, Ducongé J, Cervantes-Llano M, Blanco-Garcés E, Rodríguez V, García-Vega Y, Bello-Rivero I, Olivera-Ruano L, López-Saura P.

Biopharm Drug Dispos. 2005 May;26(4):151-9.


Bioequivalence of two recombinant interferon alpha-2b liquid formulations in healthy male volunteers.

Garcia-Garcia I, Gonzalez-Delgado CA, Valenzuela-Silva C, Hernandez-Bernal F, Ferrero-Bibilonia J, Soto-Hernandez R, Cervantes-Llano M, Ducongé J, Correa-Fernandez A, Olivera-Ruano L, Lopez-Saura P.

Drugs R D. 2004;5(5):271-80.


Beneficial effects of angiotensin-converting enzyme inhibitor and nitrate association on left ventricular remodeling in patients with large acute myocardial infarction: the Delapril Remodeling after Acute Myocardial Infarction (DRAMI) trial.

Latini R, Staszewsky L, Maggioni AP, Marino P, Hernandez-Bernal F, Tognoni G, Labarta V, Gramenzi S, Bianchi F, Sarcina G, Cremonesi G, Nicolosi GL, Geraci E; Delapril Remodeling after Acute Myocardial Infarction Collaborative Group.

Am Heart J. 2003 Jul;146(1):133.


A multicenter, randomized, double-blind clinical trial examining the effect of oral human recombinant epidermal growth factor on the healing of duodenal ulcers.

Palomino A, Hernández-Bernal F, Haedo W, Franco S, Más JA, Fernández JA, Soto G, Alonso A, González T, López-Saura P.

Scand J Gastroenterol. 2000 Oct;35(10):1016-22.


Relevance of heart rate as a prognostic factor in patients with acute myocardial infarction: insights from the GISSI-2 study.

Zuanetti G, Mantini L, Hernández-Bernal F, Barlera S, di Gregorio D, Latini R, Maggioni AP.

Eur Heart J. 1998 Jun;19 Suppl F:F19-26.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk